Thanks for clarifying. I’ll look into any recent announcements or positions related to Tylenol (acetaminophen) connected to Donald Trump, his cabinet, or relevant U.S. government departments—particularly any policy changes, health advisories, or public commentary.I’ll let you know as soon as I find credible updates or news.

Tylenol (Acetaminophen) and the Trump Administration: Recent Developments

Trump administration warnings on Tylenol and autism: On September 22, 2025 President Trump held a White House briefing (with HHS Secretary Robert F. Kennedy Jr. and others) announcing new autism initiatives – and he repeatedly cautioned pregnant women “Don’t take Tylenol…fight like hell not to take it”www.washingtonpost.comwww.cbsnews.com. News reports confirm that he told the audience the FDA will inform doctors that acetaminophen use in pregnancy “can be associated” with increased autism riskwww.cbsnews.comwww.reuters.com. For example, CBS News quoted Trump: “Effective immediately, the FDA will be notifying physicians that the use of acetaminophen during pregnancy can be associated with a very increased risk of autism,” adding “taking Tylenol is not good. I’ll say it, it’s not good”www.cbsnews.com. These statements were unscripted medical advice from the President, not based on new published studies, and drew immediate attention.President Donald Trump speaking on Sept. 22, 2025 with HHS Secretary Kennedy and others during a Rose Garden briefing on autism and drug safetywww.cbsnews.comwww.hhs.gov.FDA and HHS actions on acetaminophen: That same day, federal agencies moved to codify caution. The FDA issued a press release (Sept. 22, 2025) announcing it “initiated the process for a label change for acetaminophen (Tylenol and similar products) to reflect evidence suggesting [that prenatal use] may be associated with increased risk of neurological conditions such as autism and ADHD”www.fda.gov. FDA also sent an official letter to all physicians, advising them of the potential risk. The Department of Health and Human Services press release confirmed this, stating flatly that “the FDA will issue a physician notice and begin the process to initiate a safety label change for acetaminophen (Tylenol and similar products)”www.hhs.gov. In other words, the government is moving to add warnings to Tylenol labeling and alert doctors nationwide. Acting FDA Commissioner Marty Makary said the agency is acting “to make parents and doctors aware of a considerable body of evidence about potential risks associated with acetaminophen”www.fda.gov. (Makary noted that while studies are inconclusive, the weight of evidence justifies caution.) HHS emphasized that it still “recognizes that acetaminophen is often the only tool for fevers and pain in pregnancy,” and urged clinicians to use “the lowest effective dose for the shortest duration” if treatment is neededwww.hhs.gov. (HHS said it will also run a public-education campaign on the issuewww.hhs.gov.)HHS Secretary Robert F. Kennedy Jr., a vaccine skeptic and Trump ally, speaking at the Sept. 22, 2025 Roosevelt Room event. He announced the FDA would notify doctors and update Tylenol labeling due to possible autism riskswww.hhs.govwww.fda.gov.Official statements and context: The White House press office (on whitehouse.gov) also issued a statement backing the move, with Press Secretary Karoline Leavitt asserting “there is mounting evidence finding a connection between acetaminophen use during pregnancy and autism – and that’s why the Administration is issuing new health guidance”www.whitehouse.gov. HHS Secretary Kennedy said the new actions were “bold” steps to address a rising autism rate (“we will follow the science, restore trust, and deliver hope” to families)www.hhs.gov. CMS chief Dr. Mehmet Oz (a Trump cabinet member) praised the plan as “unprecedented” and aimed at better understanding autism causeswww.hhs.gov. The FDA’s press release and HHS release were official government documents; reporters and analysts noted that these proposals directly contradict existing medical consensus. Major health organizations (e.g. the American College of Obstetricians and Gynecologists) have long advised that acetaminophen is safe in pregnancy. The new Trump administration guidance is therefore a sharp departure.Reactions from experts and industry: Medical experts and Tylenol’s maker pushed back immediately. In a joint statement Monday evening, Tylenol-maker Kenvue said it “strongly disagrees” with any suggestion that acetaminophen causes autism and warned that without Tylenol, “women face dangerous choices” between untreated fever or riskier drugsapnews.com. ACOG President Steven Fleischman called the administration’s warning “irresponsible” and said it sends a “harmful and confusing” message to pregnant patientsapnews.com. The Society for Maternal-Fetal Medicine likewise reaffirmed that acetaminophen is the recommended first-line fever/pain reliever in pregnancy. In fact, global drug regulators (MHRA in Britain, Australia’s TGA) immediately reiterated that no evidence exists linking prenatal acetaminophen to autism and that the drug remains safe for needed use. One doctor stated bluntly on social media that “the best available science does not show an association between Tylenol use in pregnancy and an increased risk of autism”www.theguardian.com.No new COVID-19 guidance involving Tylenol has been issued by this administration. (During the pandemic, U.S. health officials did encourage use of acetaminophen for fever, but we found no recent policy updates on that front from the Trump team.) Aside from the autism announcement, the only other recent FDA action on acetaminophen has been unrelated: in June 2024, FDA proposed requiring all OTC acetaminophen labels to warn of very rare but serious skin reactionswww.fda.gov. In summary, the Trump-led administration’s recent official statements focus almost entirely on the unproven Tylenol–autism link, initiating precautionary label changes and advisories (Sept. 22, 2025)www.fda.govwww.hhs.gov. These steps have been documented in government press releases and reported by major news outlets (Reuters, Washington Post, CBS, ABC, AP, etc.)www.fda.govwww.cbsnews.comabcnews.go.com.Sources: Government press releases from HHS and FDA on Sept. 22, 2025www.hhs.govwww.fda.gov; White House press releasewww.whitehouse.gov; and media reports from Reuterswww.reuters.comwww.reuters.com, Washington Postwww.washingtonpost.com, CBS Newswww.cbsnews.com, ABC Newsabcnews.go.com, and AP Newsapnews.com. The FDA’s June 2024 monograph safety order is also citedwww.fda.gov. These sources provide dates, context, and quotes for the administration’s statements and actions on Tylenol.